Hire Rajendra Vidwans, a pharma consultant specializing in FDA Inspections. See services offered, experience summary, and connect via apicule.
Based in: India
Willing to work in: Global
Consultant Type: Independent Consultant
Expertise summary: Rajendra Vidwans is a senior GMP, QA, and audit readiness consultant with nearly five decades of experience across sterile and non-sterile dosage forms, APIs, formulations, quality systems, facility upgrades, and remediation-focused compliance support. His background includes pharma operations, production, projects, GMP audits, inspections, training, risk assessment, and third-party review programs for companies preparing for or recovering from international regulatory audits. He brings strong practical expertise in bridging the gap between written regulatory requirements and actual inspector expectations, helping organizations improve facility readiness, strengthen quality systems, and move toward sustainable compliance. - Show More
Rajendra supports FDA import alert remediation by helping companies assess the underlying quality, GMP, and operational gaps that led to regulatory action and translate those findings into practical recovery plans. His experience includes third-party facility reviews after FDA audits, detailed remediation support, quality system improvement, and guidance on corrective actions needed for re-approval and restoration of regulatory confidence. He helps organizations strengthen plant practices, personnel preparedness, and site-level compliance execution so that remediation is not only documented properly but also implemented in a way that supports sustainable regulatory recovery.
Rajendra supports FDA inspection readiness through practical pre-audit assessment, GMP systems evaluation, facility review, and focused preparation aligned with what inspectors expect to see on site. His LinkedIn profile highlights experience helping companies that are preparing for US FDA, MHRA, TGA, and WHO Geneva audits, as well as companies that need to assess their current GMP and quality status before a major inspection. He works with sites to identify readiness gaps, improve personnel training, strengthen execution discipline, and align plant operations more closely with both regulatory requirements and real inspection behavior. His approach is especially valuable for companies that need stronger on-ground readiness rather than documentation-only preparation.
Rajendra supports FDA warning letter remediation by helping companies understand where quality systems, manufacturing execution, and inspection responses have fallen short and what must be improved to regain regulatory confidence. His experience in gap analysis, remediation consulting, training in GMP requirements, and upgrading existing facilities allows him to guide organizations through structured corrective actions that address both procedural and operational weaknesses. He helps manufacturers strengthen compliance systems, improve site discipline, and implement meaningful changes that better align with inspector expectations while reducing the risk of repeat findings.
Rajendra supports FDA-483 response and remediation by helping companies review inspection observations in the context of broader site systems, plant behavior, and operational practices. His background in third-party reviews, remediation support, GMP consultancy, and facility assessment enables him to identify what requires immediate correction and what needs deeper systemic improvement. He helps organizations build more credible remediation pathways by combining practical root-level assessment with hands-on advice on quality systems, training, site readiness, and compliance execution. His strength lies in helping companies move beyond formal written responses and toward actual inspection-ready improvement.
Rajendra supports mock FDA inspections by simulating inspection-focused reviews that help companies understand how their current systems, facilities, documentation, and personnel may be viewed under regulatory scrutiny. His profile reflects experience in pre-audit assessment, third-party review, international audit support, and helping companies prepare for FDA and other global inspections. He helps sites uncover hidden readiness gaps before an actual inspection, improve staff preparedness, sharpen GMP discipline, and highlight the practical differences between internal assumptions and real inspector expectations. This makes his support especially useful for companies that want a realistic picture of their inspection readiness before a regulatory visit.
